Atlas Trials

IRD at Admission Predicts Survival of GBM Patients - a Prospective Pilot Study

Clinical trial NCT05402241 · COMPLETED

Trial details

NCT number
NCT05402241
Sponsor
University of Manitoba
Status
COMPLETED
Study type
OBSERVATIONAL
Glioblastoma Multiforme
Start date
2021-10-21
Primary completion
2023-11-15
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.